Ga-68 DOTATATE PET/CT Deep Learning Approach to Predicting Prolonged Disease Control After Lu-177 DOTATATE Therapy (EANM 2026) - Sep 29, 2026 - Abstract #OP-102; Pres time: Oct 18, 2026; 09:45 AM - 11:15 AM; Location: Hall C; "Accurate deep learning prediction of patient response to 177Lu-DOTATATE therapy is challenging, however, the approach may be useful for qualifying patients for clinical trials or for clinical reassurance, when the outcome of the prediction is positive for prolonged disease control following therapy. Predictive modeling may be more successful in future studies with larger sample sizes."
Neuroendocrine Tumor • Solid Tumor
|
|
D. Dawson 1; M. Milantoni 2; D. Laidley 1; R. Wong 3; S. Mattonen 2
|